ArticleLancet (London, England)2023

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.

Melinda J Hamer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.